A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)

Clinical trial NCT07722611 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07722611
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Polycythemia Vera

Start date: 2026-09-21
Primary completion: 2032-06-25
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.